Diacerein for the treatment of osteoarthritis
Feb 11 Following an update from the manufacturer on their regulatory timings the timelines for this MTA are to be confirmed.
- Status:
- Discontinued
- Decision:
- Selected
- Process:
- TA
- Referral date:
- 01 March 2010
- Topic area
- Musculoskeletal
- Description:
-
Scoped within batch 10
Provisional Schedule
- Closing date for invited submissions / evidence submission::
- TBC
- 1st appraisal committee meeting::
- TBC
Project Team
- Communications manager:
- TBC
- Executive Lead:
- TBC
- Project manager:
- TBC
- Technical Lead:
- TBC
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 19 January 2023 | Discontinued. Feb 11 Following an update from the manufacturer on their regulatory timings the timelines for this MTA are to be confirmed. |
| 21 December 2018 | Suspended. Suspended |
For further information on our processes and methods, please see our CHTE processes and methods manual